• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Philips inks ambulatory cardiac monitoring collab with Epic

Philips inks ambulatory cardiac monitoring collab with Epic

July 24, 2025 By Sean Whooley

Philips Epic Aura integration (1)
[Image courtesy of Philips/Epic]

Philips (NYSE: PHG) announced today that it entered into a collaboration with Epic to integrate cardiac ambulatory monitoring and diagnostic services.

The collaboration integrates the Philips services with Aura, the specialty diagnostics suite of the leading electronic health record (EHR) company.

According to Philips, the collaboration should offer the broadest cardiac care portfolio of any single service provider integrating with Aura to date. Epic has a number of partnerships across medtech for Aura, including with the likes of iRhythm and Abbott.

Philips says it expects to deliver a new level of interoperability between its ambulatory monitoring technologies and Epic. It hopes to help providers enhance the diagnostic process and improve patient outcomes. With these technologies available through Aura, health system IT teams can reduce the time it takes to connect with Philips. They can also give interested provider organizations the ability to order and review ECG results directly in Epic. This cuts out the need for manual order and data entry, enhancing workflows and streamlining decision-making.

“With this collaboration, we are advancing cardiac care in a way that simultaneously improves the clinician and patient experience,” said Stefano Folli, business leader, Ambulatory Monitoring & Diagnostics, Philips. “Together, Philips and Epic can help enable workflow efficiencies that lighten cardiac care teams’ load, so they can spend more time focusing on what matters most – providing direct patient care.”

The collaboration can also streamline administrative tasks through automation, notifications and charting, the companies said.

“Through this collaboration, we’re streamlining the clinical experience for both patients and physicians, reducing administrative overhead and ensuring that detailed diagnostic reports are readily available in the patient’s comprehensive health record,” said Leah Johnson, VP of cardiology and imaging diagnostics, Epic.

Filed Under: Big Data, Business/Financial News, Cardiovascular, Diagnostics, Digital Health, Electronic Medical Records (EMR), Featured, Health Information Technology, Health Technology, Hospital Care, Patient Monitoring, Software / IT Tagged With: Epic, Philips, Royal Philips

More recent news

  • Cooper Companies continues to see activist pressure to sell divisions, replace CEO
  • Cordis earns FDA nod for Selution SLR drug-eluting balloon
  • Siemens Healthineers links with Novo to advance liver fibrosis blood test
  • GE HealthCare rolls out AI software for predicting care bottlenecks
  • Wandercraft’s self-balancing Eve exoskeleton begins US launch

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy